Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 2 |
Descriptor
Author
| Alpert, Kathryn I. | 1 |
| Clasen, Liv | 1 |
| Gogtay, Nitin | 1 |
| Greenstein, Deanna | 1 |
| Hall, S. S. | 1 |
| Hammond, J. L. | 1 |
| Hirt, M. | 1 |
| Johnson, Sarah L. M. | 1 |
| Lalonde, Francois | 1 |
| Miller, Rachel | 1 |
| Rapoport, Judith | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Wechsler Intelligence Scale… | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkJohnson, Sarah L. M.; Wang, Lei; Alpert, Kathryn I.; Greenstein, Deanna; Clasen, Liv; Lalonde, Francois; Miller, Rachel; Rapoport, Judith; Gogtay, Nitin – Journal of the American Academy of Child & Adolescent Psychiatry, 2013
Objective: The hippocampus has been implicated in the pathogenesis of schizophrenia, and hippocampal volume deficits have been a consistently reported abnormality, but the subregional specificity of the deficits remains unknown. The authors explored the nature and developmental trajectory of subregional shape abnormalities of the hippocampus in…
Descriptors: Genetics, Children, Pathology, Attention Deficit Disorders
Hall, S. S.; Hammond, J. L.; Hirt, M.; Reiss, A. L. – Journal of Intellectual Disability Research, 2012
Background: Clinical trials of medications to alleviate the cognitive and behavioural symptoms of individuals with fragile X syndrome (FXS) are now underway. However, there are few reliable, valid and/or sensitive outcome measures available that can be directly administered to individuals with FXS. The majority of assessments employed in clinical…
Descriptors: Outcome Measures, Test Validity, Feedback (Response), Reinforcement
